Literature DB >> 27231097

Intervention improves assisted conception intracytoplasmic sperm injection outcomes for patients with high levels of sperm DNA fragmentation: a retrospective analysis.

C K Bradley1, S J McArthur1, A J Gee1, K A Weiss1, U Schmidt2, L Toogood1.   

Abstract

Sperm DNA fragmentation (SDF) is used in assisted reproductive technology (ART) programs as an indicator for sperm quality, although there is still a lack of consensus as to its clinical utility. In this retrospective study, we examined intracytoplasmic sperm injection (ICSI) outcomes of 1924 infertile patients who underwent SDF analysis using the sperm chromatin integrity test. ART patients were classified as having low [DNA fragmentation index (DFI) <29%] or high SDF (DFI ≥29%) and by whether or not an intervention [physiological intracytoplasmic sperm injection (PICSI), intracytoplasmic morphologically selected sperm injection (IMSI), testicular sperm extraction (TESE)/testicular sperm aspiration (TESA), frequent ejaculation] was performed. High SDF patients who did not have an intervention had a lower fertilization rate and poorer clinical outcomes from blastocyst transfers as compared with low SDF patients; the fertilization rate was 66.0% vs. 70.2% (p = 0.042), single embryo transfer (SET) fetal heart pregnancy rate was 28.5% vs. 45.2% (p = 0.042), and SET live birth rate was 24.9% vs. 40.6% (p = 0.060), respectively. Furthermore, high SDF patients who had an intervention had significantly improved blastocyst transfer outcomes, similar to those of low SDF patients; the SET live birth rate for high SDF intervention patients was 43.8% as compared with 24.9% for high SDF no intervention patients (p = 0.037) and 40.6% for low SDF patients (p = 0.446). Analysis of the three main intervention subgroups for high SDF patients revealed that TESE/TESA patients had the highest SET live birth rate; in comparison with 24.2% for high SDF patients who did not have an intervention, PICSI patients had 38.3% (p = 0.151), IMSI patients had 28.7% (p = 0.680), and TESE/TESA patients had 49.8% (p = 0.020). Our data suggest that SDF results indicate ICSI outcomes and that patients who have high SDF benefit from an intervention.
© 2016 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  SCIT; male infertility; sperm DNA fragmentation; sperm chromatin integrity test; testicular sperm

Mesh:

Year:  2016        PMID: 27231097     DOI: 10.1111/andr.12215

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  37 in total

1.  Switching to testicular sperm after a previous ICSI failure with ejaculated sperm significantly improves blastocyst quality without increasing aneuploidy risk.

Authors:  Irene Hervas; Maria Gil Julia; Rocío Rivera-Egea; Ana Navarro-Gomezlechon; Laura Mossetti; Nicolás Garrido
Journal:  J Assist Reprod Genet       Date:  2022-08-16       Impact factor: 3.357

Review 2.  Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations.

Authors:  Sandro C Esteves; Armand Zini; Robert Matthew Coward; Donald P Evenson; Jaime Gosálvez; Sheena E M Lewis; Rakesh Sharma; Peter Humaidan
Journal:  Andrologia       Date:  2020-10-27       Impact factor: 2.775

Review 3.  The Use of Testicular Sperm for Intracytoplasmic Sperm Injection in Patients with High Sperm DNA Damage: A Systematic Review.

Authors:  Rafael F Ambar; Ashok Agarwal; Ahmad Majzoub; Sarah Vij; Nicholas N Tadros; Chak Lam Cho; Neel Parekh; Edson Borges; Sidney Glina
Journal:  World J Mens Health       Date:  2020-06-25       Impact factor: 5.400

Review 4.  Recent advances in understanding & managing male infertility.

Authors:  Jared M Bieniek; Kirk C Lo
Journal:  F1000Res       Date:  2016-11-24

Review 5.  Use of testicular sperm for intracytoplasmic sperm injection in men with high sperm DNA fragmentation: a SWOT analysis.

Authors:  Sandro C Esteves; Matheus Roque; Nicolás Garrido
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

6.  Current limitation and future perspective of sperm DNA fragmentation tests.

Authors:  Ashok Agarwal; Chak-Lam Cho; Sandro C Esteves; Ahmad Majzoub
Journal:  Transl Androl Urol       Date:  2017-09

7.  Technical aspects of sperm DNA fragmentation testing, methods to select sperm with low DNA fragmentation, and usefulness of redox potential measurement in male infertility.

Authors:  Sandro C Esteves; Ahmad Majzoub; Ashok Agarwal
Journal:  Transl Androl Urol       Date:  2017-09

8.  A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation testing in specific male infertility scenarios.

Authors:  Sandro C Esteves; Ashok Agarwal; Chak-Lam Cho; Ahmad Majzoub
Journal:  Transl Androl Urol       Date:  2017-09

9.  Call for wider application of sperm DNA fragmentation test.

Authors:  Ashok Agarwal; Chak-Lam Cho; Ahmad Majzoub; Sandro C Esteves
Journal:  Transl Androl Urol       Date:  2017-09

10.  Sperm DNA fragmentation testing: a cross sectional survey on current practices of fertility specialists.

Authors:  Ahmad Majzoub; Ashok Agarwal; Chak-Lam Cho; Sandro C Esteves
Journal:  Transl Androl Urol       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.